(Total Views: 861)
Posted On: 03/31/2021 11:53:02 PM
Post# of 153903
Dr Jay Lalezari stated emphatically that he disagreed with that and fought for more doses and IV administration.. it's not hard to see why the FDA prevailed. "2 doses or we don't approve your study".. what's your response to that?
Quote:
And it's equally unclear why the Amarex people who knew very well about the half life of leronlimab agreed to toe the FDA line and doom the trial before it started!
Read More: https://investorshangout.com/post/newpost/605...z6qkij5zb7
(2)
(0)
